Haddad A - Search Results

1

MicroRNA-940 as a Potential Serum Biomarker for Prostate Cancer.

Rajendiran S, Maji S, Haddad A, Lotan Y, Nandy RR, Vishwanatha JK, Chaudhary P. Rajendiran S, et al. Among authors: haddad a. Front Oncol. 2021 Mar 19;11:628094. doi: 10.3389/fonc.2021.628094. eCollection 2021. Front Oncol. 2021. PMID: 33816263 Free PMC article.

2

Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma.

Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Darwish OM, Haddad AQ, Khalil D, Kapur P, Sagalowsky AI, Lotan Y, Margulis V. Krabbe LM, et al. Among authors: haddad aq. J Urol. 2014 Jun;191(6):1671-7. doi: 10.1016/j.juro.2013.11.052. Epub 2013 Nov 26. J Urol. 2014. PMID: 24291548

3

From genomics to imaging-advances along the care continuum.

Haddad A, Lotan Y. Haddad A, et al. Nat Rev Urol. 2014 Feb;11(2):71-3. doi: 10.1038/nrurol.2013.286. Epub 2013 Dec 10. Nat Rev Urol. 2014. PMID: 24323128

4

Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.

Chung PH, Krabbe LM, Darwish OM, Westerman ME, Bagrodia A, Gayed BA, Haddad AQ, Kapur P, Sagalowsky AI, Lotan Y, Margulis V. Chung PH, et al. Among authors: haddad aq. Urol Oncol. 2014 Oct;32(7):981-8. doi: 10.1016/j.urolonc.2014.02.018. Epub 2014 Jul 9. Urol Oncol. 2014. PMID: 25022858

5

Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma.

Haddad AQ, Kapur P, Singla N, Raman JD, Then MT, Nuhn P, Buchner A, Bastian P, Seitz C, Shariat SF, Bensalah K, Rioux-Leclercq N, Sagalowsky A, Lotan Y, Margulis V. Haddad AQ, et al. Cancer. 2015 Jan 1;121(1):43-50. doi: 10.1002/cncr.28976. Epub 2014 Sep 3. Cancer. 2015. PMID: 25186283 Free article.

6

Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.

Krabbe LM, Bagrodia A, Haddad AQ, Kapur P, Khalil D, Hynan LS, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V. Krabbe LM, et al. Among authors: haddad aq. J Urol. 2015 May;193(5):1486-93. doi: 10.1016/j.juro.2014.11.007. Epub 2014 Nov 11. J Urol. 2015. PMID: 25451830

7

Association of distance to treatment facility on quality and survival outcomes after radical cystectomy for bladder cancer.

Haddad AQ, Singla N, Gupta N, Raj GV, Sagalowsky AI, Margulis V, Lotan Y. Haddad AQ, et al. Urology. 2015 Apr;85(4):876-82. doi: 10.1016/j.urology.2014.12.024. Urology. 2015. PMID: 25817110

8

Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy.

Lotan Y, Haddad AQ, Costa DN, Pedrosa I, Rofsky NM, Roehrborn CG. Lotan Y, et al. Urol Oncol. 2015 Jun;33(6):266.e9-16. doi: 10.1016/j.urolonc.2015.03.007. Epub 2015 Apr 7. Urol Oncol. 2015. PMID: 25858102

9

Long-term outcomes in a high-risk bladder cancer screening cohort.

Starke N, Singla N, Haddad A, Lotan Y. Starke N, et al. Among authors: haddad a. BJU Int. 2016 Apr;117(4):611-7. doi: 10.1111/bju.13154. Epub 2015 Jun 3. BJU Int. 2016. PMID: 25891519

10

Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?

Krabbe LM, Bagrodia A, Westerman ME, Gayed BA, Haddad AQ, Sagalowsky AI, Shariat SF, Kapur P, Lotan Y, Margulis V. Krabbe LM, et al. Among authors: haddad aq. World J Urol. 2016 Jan;34(1):105-12. doi: 10.1007/s00345-015-1584-6. Epub 2015 May 20. World J Urol. 2016. PMID: 25991599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,281 results

Search Page